Funding Clinical Trials

Funding Clinical Trials

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.

CIRM Clinical Dashboard

Disease Areassort descending Investigator Organization Phase Trial Status Targeted Enrollment Detail
Thomas Kipps University of California, San Diego Phase 1/2 Active, not recruiting 102
David Miklos Stanford University Phase 1 Recruiting 60
  • B cell cancers
  • Leukemia
  • Leukemia, Acute Myeloid (AML)
 Matthew Porteus Stanford University Phase 1 Recruiting 22
  • B cell cancers
 Paul Finnegan Angiocrine Bioscience, Inc. Phase 3 Recruiting 148
Edward Kavalerchik Angiocrine Bioscience, Inc. Phase 1 Completed 10
Thomas Kipps University of California, San Diego Phase 1 Completed 26
Irving Weissman Stanford University Phase 1 Completed 88
Michael Pulsipher Children's Hospital of Los Angeles Phase 1/2 Active, not recruiting 60
Edward Kavalerchik Angiocrine Bioscience, Inc. Phase 1 Completed 42
Mehrdad Abedi University of California, Davis Phase 1/2 Recruiting 18
  • Leukemia, Acute Myeloid (AML)
 Colleen Delaney Nohla Therapeutics Inc Phase 2 Closed 146
  • Leukemia, Acute Myeloid (AML)
 Mark Chao Forty Seven Inc. Phase 1 Active, not recruiting 258
  • Leukemia, Acute Myeloid (AML)
 Joseph Woodard Immune-Onc Therapeutics Phase 1 Recruiting 122
  • Multiple Myeloma
 Rajesh Belani Poseida Therapeutics, Inc. Phase 1 Closed 105
Icon for XLSX export